STOCK TITAN

BCAX: Insider files Form 144 to sell 9,200 shares (05/21/2026)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BCAX notice of proposed sale: a holder filed a Form 144 reporting an intended sale of 9,200 shares of Common Stock on 05/21/2026 related to an exercise of stock options and settled in cash. The filing also lists multiple prior dispositions in March–April 2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 documents planned resale after option exercise and shows recent dispositions.

The notice reports an intended sale of 9,200 shares on 05/21/2026, described as resulting from an exercise of stock options and to be effected in cash. The excerpt lists prior sales of Common Stock on 03/03/2026, 03/04/2026, 03/23/2026, and 04/21/2026 with exact share and dollar amounts.

These entries reflect routine resale mechanics under Section 16 resale notice practice; the filing does not state purchaser identity, proceeds recipient beyond "Issuer" in the exercise row, or any market‑timing restrictions. Subsequent filings would show final settlement details and any Rule 144 volume/holding compliance.

Planned sale 9,200 shares Intended sale on 05/21/2026 from exercise of stock options
Estimated value (row) $187,883.32 Value listed alongside the 9,200‑share 05/21/2026 row
Past sale 03/03/2026 13,555 shares Disposition on 03/03/2026 for $246,909.75
Past sale 03/04/2026 2,963 shares Disposition on 03/04/2026 for $54,061.71
Past sale 03/23/2026 9,200 shares Disposition on 03/23/2026 for $170,348.12
Past sale 04/21/2026 9,200 shares Disposition on 04/21/2026 for $211,613.80
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
exercise of stock options financial
"Common | 05/21/2026 | Exercise of stock options"
cash financial
"05/21/2026 | Exercise of stock options | Issuer | | | 9200 | 05/21/2026 | Cash"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does BCAX's Form 144 report about the planned sale?

The Form 144 reports an intended sale of 9,200 shares of Common Stock on 05/21/2026 tied to an exercise of stock options. The filing records the method as cash and lists recent prior dispositions in March–April 2026.

How many shares and dollar amounts were sold by the filer in recent months?

The filing lists past dispositions of 13,555 shares ($246,909.75) on 03/03/2026 and 2,963 shares ($54,061.71) on 03/04/2026. It also shows 9,200 shares on 03/23/2026 ($170,348.12) and on 04/21/2026 ($211,613.80).

Is the planned sale associated with an option exercise or open‑market sale?

The excerpt explicitly lists the 05/21/2026 row as an exercise of stock options with settlement in cash. Other dated entries are recorded as sales during the past three months without additional method details in the excerpt.

Who receives proceeds from the reported transactions in the filing?

The exercise row identifies Issuer in the related column, indicating the exercise generated cash proceeds tied to the issuer. The filing excerpt does not state purchaser identities or detailed proceeds allocation for each prior sale.